Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-04 | 2024-09 | 0.06 | N/A | N/A | N/A |
2024-08-14 | 2024-06 | 0.02 | -0.03 | -0.05 | -250.00% |
2024-05-10 | 2024-03 | 0 | -0.06 | N/A | N/A |
2024-03-14 | 2023-12 | -0.03 | -0.07 | -0.04 | -133.33% |
2023-11-06 | 2023-09 | -0.07 | -0.04 | 0.03 | 42.86% |
2023-08-07 | 2023-06 | -0.04 | 0.21 | 0.25 | 625.00% |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-31 | BASHAN DROR | Chief Executive Officer | 0.00 | Stock Award(Grant) |
2016-12-01 | CAMBER CAPITAL MANAGEMENT L L C | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2021-06-02 | DEXCEL PHARMA TECHNOLOGIES, LTD. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-08-14 | HAYON YAEL | Officer | 0.00 | Stock Award(Grant) |
2015-12-13 | MAIMON YOSSI | Chief Financial Officer | 195.00K | Purchase |
2017-05-15 | MANOR MOSHE | Chief Executive Officer | 50.00K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 2.64M | 5.28M | 3.69% |
2023-06-29 | State Street Corporation | 731.24K | 1.46M | 1.02% |
2023-06-29 | Renaissance Technologies, LLC | 659.30K | 1.32M | 0.92% |
2023-06-29 | Marshall Wace LLP | 562.14K | 1.12M | 0.79% |
2023-06-29 | Geode Capital Management, LLC | 552.37K | 1.10M | 0.77% |
2023-06-29 | Northern Trust Corporation | 362.91K | 725.83K | 0.51% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | iShares Russell 2000 ETF | 1.19M | 2.25M | 1.66% |
2023-07-30 | Fidelity Small Cap Index Fund | 491.59K | 786.55K | 0.69% |
2023-08-30 | iShares Russell 2000 Value ETF | 469.13K | 886.65K | 0.66% |
2023-07-30 | TIAA-CREF Funds-Equity Index Fund | 176.99K | 283.19K | 0.25% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 155.00K | 310.00K | 0.22% |
2023-07-30 | Schwab Capital Trust-Small Cap Index Fund | 128.42K | 205.47K | 0.18% |
Split | Date |
---|---|
1 : 10 | 2019-12-20 |
0.1 : 1 | 2007-01-03 |
-
Strong volume again today don’t get shook
-
Letssss goooooo
-
FDA approval obviously leaked . Massive
Volume , insider buys , jp Morgan bought 2m shares yesterday lolGapping up to $6 by sept 9th
-
Gap up time after hours tonight
-
Volume looks good today , flow is bullish . Let’s retake $1.50 and continue the uptrend heading into fda approval next week where we break $10
-
time to gap up RIP ️
-
Gapping up after hours means shorts are stuck $2.80 tomorrow
-
Adding this dip , about to reverse and head for $1.45 GL
-
Insider buys
FDA approval coming September 9th
52 week lows
Gaps to fill on chart.This is as risk free as it gets .
-
Somebody knows FDA approval is coming on September 9th this should run heading into it
-
Ripping AH. ???
-
This is rock bottom
PR out this morning
Hot sector
FDA approval scheduled for September 9th (Thursday) which analysts say has an 80% chance of going through.
Zacks has a $12.50 price target on this.
Chart has two gaps to fill $2.90 area being the first goal
Very easy buy down here. Good luck
-
runner runner
-
$PLX - though I walk through the valley of the shadow of death, I will fear no evil: for thou art with me; thy rod and thy staff they comfort me...
-
Chooo....Chooo!!!
-
Boom soon !!
-
Wow...almost 1 million volume, 9x is times average!!